國家衛生研究院 NHRI:Item 3990099045/6182

NHRI > National Institute of Infectious Diseases and Vaccinology > Tsai-Ling Yang Lauderdale > Periodical Articles > Item 3990099045/6182

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/6182

Title:	A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan
Authors:	Wu, H;Wang, JT;Shiau, YR;Wang, HY;Yang Lauderdale, TL;Chang, SC
Contributors:	Division of Infectious Diseases
Abstract:	Background: Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen in debilitated hosts. Clinical management of S. maltophilia is challenging due to its intrinsic resistance to a variety of antibiotics. This study investigated the trend and prevalence of antimicrobial resistance in S. maltophilia from a nationwide surveillance study in Taiwan. Methods: S. maltophilia isolates were collected biennially between 1998 and 2008 as part of the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program from medical centers and regional hospitals throughout Taiwan. Minimal inhibitory concentrations (MIC) were determined using the Clinical and Laboratory Standards Institute reference broth microdilution method. Results: A total of 377 non-duplicate S. maltophilia isolates were collected from 38 hospitals. The majority of the isolates were from the respiratory tract (256, 67.9%), followed by blood (48, 12.7%). Overall, 376 (99.7%) isolates were susceptible to minocycline, 362 (96%) to tigecycline, 311 (82.5%) to trimethoprim/sulfamethoxazole (TMP-SMX), 300 (79.6%) to levofloxacin, 92 (24.4%) to ceftazidime, and 70 (18.6%) to ticarcillin-clavulanic acid. The MIC50/MIC90 of minocycline, tigecycline, TMP-SMX, levofloxacin, ceftazidime, and ticarcillin-clavulanic acid, were ?0.5/1 μg/mL, 0.25/1 μg/mL, ?0.25/8 μg/mL, 1/4 μg/mL, 32/128 μg/mL, and 64/128 μg/mL, respectively. A trend of increased non-susceptibility to levofloxacin (p = 0.014) was observed over the 10-year study period. Compared to TMP-SMX-susceptible isolates, TMP-SMX-resistant isolates were less susceptible to levofloxacin (54.5% vs. 84.9%, p < 0.001). Conclusion: In this 10-year study, minocycline and TMP-SMX remained the two antimicrobials with better in?vitro activities against S. maltophilia than ceftazidime, levofloxacin, and ticarcillin-clavulanic acid. The activity of levofloxacin against S. maltophilia in Taiwan declined during the past 10 years.
Date:	2012-04
Relation:	Journal of Microbiology, Immunology and Infection. 2012 Apr;45(2):120-126.
Link to:	http://dx.doi.org/10.1016/j.jmii.2011.09.028
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1684-1182&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000304215000007
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84859878039
Appears in Collections:	[Tsai-Ling Yang Lauderdale] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP82955251136.pdf		399Kb	Adobe PDF	305	View/Open

Loading...